Session 6 Primary prevention of breast cancer II: Update of chemoprevention with tamoxifen, raloxifen and aromatase-inhibitors: S17. Aromatase inhibitors in breast cancer prevention: The IBIS-II trialJ. Cuzick · 2004

Session 6 Primary prevention of breast cancer II: Update of chemoprevention with tamoxifen, raloxifen and aromatase-inhibitors: S18. Breast cancer chemoprevention: Quo vadis?T. Powles · 2004

Session 6 Primary prevention of breast cancer II: Update of chemoprevention with tamoxifen, raloxifen and aromatase-inhibitors: S15. The US breast cancer-prevention trials (NSABP-P1, MORE, STAR)V. Vogel; D. Wickerham; J. Costantino; W. Cronin; N. Wolmark · 2004

Fenretinide and cancer preventionRosalba Torrisi; Andrea Decensi · 2000

Endocrine therapy in ovarian cancerPaleari, Laura; DeCensi, Andrea · Current Opinion in Obstetrics and Gynecology · 2017

An Abstract Provides “seAFOod” for ThoughtDeCensi, Andrea; Gescher, Andreas · Cancer Prevention Research · 2019

Pharmacological prevention of breast cancer: Quo vadis?Andrea Decensi · 2003

Progress in chemoprevention of breast cancerDavide Serrano; Elisa Perego; Alberto Costa; Andrea Decensi · 2004

SERMs in chemoprevention of breast cancerMilena Gasco; Alessandra Argusti; Bernardo Bonanni; Andrea Decensi · 2005

Retinoids and tamoxifen in breast cancer chemopreventionAlberto Costa; Virgilio Sacchini; Andrea Decensi · 1993

Breast Cancer Prevention Trials Using RetinoidsAndrea Decensi; Davide Serrano; Bernardo Bonanni; Massimiliano Cazzaniga; Aliana Guerrieri-Gonzaga · 2003